Bini Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 07-12-2024
- Paid Up Capital ₹ 1.50 M
as on 07-12-2024
- Company Age 44 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 3.64%
(FY 2023)
- Profit 10.45%
(FY 2023)
- Ebitda 20.69%
(FY 2023)
- Net Worth 14.20%
(FY 2023)
- Total Assets 5.80%
(FY 2023)
About Bini Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Poonam Badlani, Neeraj Badlani, Dinesh Badlani, and One other member serve as directors at the Company.
- CIN/LLPIN
U24200MH1980PTC022104
- Company No.
022104
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 1980
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Bini Laboratories Private Limited offer?
Bini Laboratories Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs.
Who are the key members and board of directors at Bini Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Poonam Badlani  | Director | 23-May-1989 | Current |
| Neeraj Badlani | Director | 02-Apr-2005 | Current |
| Dinesh Badlani | Director | 01-Aug-1995 | Current |
| Divya Badlani | Director | 01-Apr-2010 | Current |
Financial Performance of Bini Laboratories.
Bini Laboratories Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.64% increase. The company also saw a substantial improvement in profitability, with a 10.45% increase in profit. The company's net worth Soared by an impressive increase of 14.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bini Laboratories?
In 2023, Bini Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sona Metal Containers Private LimitedActive 45 years 7 monthsPoonam Badlani, Neeraj Badlani and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bini Laboratories?
Bini Laboratories has a workforce of 25 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bini Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bini Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
